BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Casari I, Manfredi M, Metharom P, Falasca M. Dissecting lipid metabolism alterations in SARS-CoV-2. Prog Lipid Res 2021;82:101092. [PMID: 33571544 DOI: 10.1016/j.plipres.2021.101092] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 20.5] [Reference Citation Analysis]
Number Citing Articles
1 Doğan K, Bolat S, Öksüz C, Büyüktuna SA. Leukotriene metabolism and proiflammatory cytokines in Crimean Congo hemorrhagic fever. J Med Virol 2023;95:e28199. [PMID: 36207793 DOI: 10.1002/jmv.28199] [Reference Citation Analysis]
2 Teodori L, Osimani B, Isidoro C, Ramakrishna S. Mass versus personalized medicine against COVID-19 in the "system sciences" era. Cytometry A 2022;101:995-9. [PMID: 35716116 DOI: 10.1002/cyto.a.24662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 He L, Wang Q, Liang X, Wang H, Chu P, Yang C, Li Y, Liao L, Zhu Z, Wang Y. Grass Carp Reovirus Induces Formation of Lipid Droplets as Sites for Its Replication and Assembly. mBio 2022. [DOI: 10.1128/mbio.02297-22] [Reference Citation Analysis]
4 Toelzer C, Gupta K, Yadav SKN, Hodgson L, Williamson MK, Buzas D, Borucu U, Powers K, Stenner R, Vasileiou K, Garzoni F, Fitzgerald D, Payré C, Gautam G, Lambeau G, Davidson AD, Verkade P, Frank M, Berger I, Schaffitzel C. The free fatty acid-binding pocket is a conserved hallmark in pathogenic β-coronavirus spike proteins from SARS-CoV to Omicron. Sci Adv 2022;8:eadc9179. [PMID: 36417532 DOI: 10.1126/sciadv.adc9179] [Reference Citation Analysis]
5 Žarković N, Łuczaj W, Jarocka-karpowicz I, Orehovec B, Baršić B, Tarle M, Kmet M, Lukšić I, Biernacki M, Skrzydlewska E. Diversified Effects of COVID-19 as a Consequence of the Differential Metabolism of Phospholipids and Lipid Peroxidation Evaluated in the Plasma of Survivors and Deceased Patients upon Admission to the Hospital. IJMS 2022;23:11810. [DOI: 10.3390/ijms231911810] [Reference Citation Analysis]
6 Occelli C, Guigonis J, Lindenthal S, Cagnard A, Graslin F, Brglez V, Seitz-polski B, Dellamonica J, Levraut J, Pourcher T. Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19. Front Med 2022;9. [DOI: 10.3389/fmed.2022.995069] [Reference Citation Analysis]
7 Kumar R, Kumar V, Arya R, Anand U, Priyadarshi RN. Association of COVID-19 with hepatic metabolic dysfunction. World J Virol 2022; 11(5): 237-251 [DOI: 10.5501/wjv.v11.i5.237] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kruger A, Vlok M, Turner S, Venter C, Laubscher GJ, Kell DB, Pretorius E. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc Diabetol 2022;21:190. [PMID: 36131342 DOI: 10.1186/s12933-022-01623-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang T, Cao Y, Zhang H, Wang Z, Man CH, Yang Y, Chen L, Xu S, Yan X, Zheng Q, Wang YP. COVID-19 metabolism: Mechanisms and therapeutic targets. MedComm (2020) 2022;3:e157. [PMID: 35958432 DOI: 10.1002/mco2.157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Pelle MC, Zaffina I, Provenzano M, Moirano G, Arturi F. COVID-19 and diabetes—Two giants colliding: From pathophysiology to management. Front Endocrinol 2022;13:974540. [DOI: 10.3389/fendo.2022.974540] [Reference Citation Analysis]
11 Theodoropoulou MA, Koutoulogenis GS, Zhang L, Akrani I, Mikros E, Hilgenfeld R, Kokotos G. Identification of a Dual Inhibitor of Secreted Phospholipase A2 (GIIA sPLA2) and SARS-CoV-2 Main Protease. Pharmaceuticals 2022;15:961. [DOI: 10.3390/ph15080961] [Reference Citation Analysis]
12 Lam SM, Huang X, Shui G. Neurological aspects of SARS-CoV-2 infection: lipoproteins and exosomes as Trojan horses. Trends Endocrinol Metab 2022;33:554-68. [PMID: 35613979 DOI: 10.1016/j.tem.2022.04.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Karu N, Kindt A, Lamont L, van Gammeren AJ, Ermens AAM, Harms AC, Portengen L, Vermeulen RCH, Dik WA, Langerak AW, van der Velden VHJ, Hankemeier T. Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers. Metabolites 2022;12:619. [DOI: 10.3390/metabo12070619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Agrawal P, Sambaturu N, Olgun G, Hannenhalli S. A Path-Based Analysis of Infected Cell Line and COVID-19 Patient Transcriptome Reveals Novel Potential Targets and Drugs Against SARS-CoV-2. Front Immunol 2022;13:918817. [DOI: 10.3389/fimmu.2022.918817] [Reference Citation Analysis]
15 Nguyen V, Zhang Y, Gao C, Cao X, Tian Y, Carver W, Kiaris H, Cui T, Tan W. The Spike Protein of SARS-CoV-2 Impairs Lipid Metabolism and Increases Susceptibility to Lipotoxicity: Implication for a Role of Nrf2. Cells 2022;11. [PMID: 35741045 DOI: 10.3390/cells11121916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Nguyen NTH, Ou TY, Huy LD, Shih C, Chang Y, Phuc PT, Huang C. A global analysis of COVID-19 infection fatality rate and its associated factors during the Delta and Omicron variant periods: Observational study (Preprint).. [DOI: 10.2196/preprints.40263] [Reference Citation Analysis]
17 Pike DP, Mcguffee RM, Geerling E, Albert CJ, Hoft DF, Shashaty MGS, Meyer NJ, Pinto AK, Ford DA. Plasmalogen Loss in Sepsis and SARS-CoV-2 Infection. Front Cell Dev Biol 2022;10:912880. [DOI: 10.3389/fcell.2022.912880] [Reference Citation Analysis]
18 Castañé H, Iftimie S, Baiges-Gaya G, Rodríguez-Tomàs E, Jiménez-Franco A, López-Azcona AF, Garrido P, Castro A, Camps J, Joven J. Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients. Metabolism 2022;131:155197. [PMID: 35381232 DOI: 10.1016/j.metabol.2022.155197] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
19 Ruan X, Wang Y, Zhou L, Zheng Q, Hao H, He D. Evaluation of Untargeted Metabolomic Strategy for the Discovery of Biomarker of Breast Cancer. Front Pharmacol 2022;13:894099. [DOI: 10.3389/fphar.2022.894099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Woollam M, Angarita-Rivera P, Siegel AP, Kalra V, Kapoor R, Agarwal M. Exhaled VOCs can discriminate subjects with COVID-19 from healthy controls. J Breath Res 2022;16. [PMID: 35453137 DOI: 10.1088/1752-7163/ac696a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Hu S, Buser E, Arredondo J, Relyea D, Santos Rocha C, Dandekar S. Altered Expression of ACE2 and Co-receptors of SARS-CoV-2 in the Gut Mucosa of the SIV Model of HIV/AIDS. Front Microbiol 2022;13:879152. [PMID: 35495669 DOI: 10.3389/fmicb.2022.879152] [Reference Citation Analysis]
22 Toelzer C, Gupta K, Yadav SK, Hodgson L, Williamson MK, Buzas D, Borucu U, Powers K, Stenner R, Vasileiou K, Garzoni F, Fitzgerald D, Payré C, Lambeau G, Davidson AD, Verkade P, Frank M, Berger I, Schaffitzel C. The Free Fatty Acid-Binding Pocket is a Conserved Hallmark in Pathogenic β-Coronavirus Spike Proteins from SARS-CoV to Omicron.. [DOI: 10.1101/2022.04.22.489083] [Reference Citation Analysis]
23 Nguyen V, Zhang Y, Gao C, Cao X, Tian Y, Carver W, Kiaris H, Cui T, Tan W. The Spike protein of SARS-CoV-2 impairs lipid metabolism and increases susceptibility to lipotoxicity: implication for a role of Nrf2.. [DOI: 10.1101/2022.04.19.488806] [Reference Citation Analysis]
24 Rong P, Wang J, Angelova A, Almsherqi ZA, Deng Y. Plasmalogenic Lipid Analogs as Platelet-Activating Factor Antagonists: A Potential Novel Class of Anti-inflammatory Compounds. Front Cell Dev Biol 2022;10:859421. [DOI: 10.3389/fcell.2022.859421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Cortes GM, Marcialis MA, Bardanzellu F, Corrias A, Fanos V, Mussap M. Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin. Front Microbiol 2022;13:856165. [PMID: 35391730 DOI: 10.3389/fmicb.2022.856165] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
26 Kim HK, Kim H, Lee MK, Choi WH, Jang Y, Shin JS, Park J, Bae DH, Hyun S, Kim KH, Han HW, Lim B, Choi G, Kim M, Chang Lim Y, Yoo J. Generation of human tonsil epithelial organoids as an ex vivo model for SARS-CoV-2 infection. Biomaterials 2022;283:121460. [DOI: 10.1016/j.biomaterials.2022.121460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Zhao J, Chen J, Wang C, Liu Y, Li M, Li Y, Li R, Han Z, Wang J, Chen L, Shu Y, Cheng G, Sun C. Kynurenine-3-monooxygenase (KMO) broadly inhibits viral infections via triggering NMDAR/Ca2+ influx and CaMKII/ IRF3-mediated IFN-β production. PLoS Pathog 2022;18:e1010366. [PMID: 35235615 DOI: 10.1371/journal.ppat.1010366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Costanzo M, Caterino M, Fedele R, Cevenini A, Pontillo M, Barra L, Ruoppolo M. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19. Int J Mol Sci 2022;23:2414. [PMID: 35269564 DOI: 10.3390/ijms23052414] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 18.0] [Reference Citation Analysis]
29 Staufer O, Gupta K, Hernandez Bücher JE, Kohler F, Sigl C, Singh G, Vasileiou K, Yagüe Relimpio A, Macher M, Fabritz S, Dietz H, Cavalcanti Adam EA, Schaffitzel C, Ruggieri A, Platzman I, Berger I, Spatz JP. Synthetic virions reveal fatty acid-coupled adaptive immunogenicity of SARS-CoV-2 spike glycoprotein. Nat Commun 2022;13. [DOI: 10.1038/s41467-022-28446-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
30 Litwack G. Metabolism of Fat, Carbohydrate, and Nucleic Acids. Human Biochemistry 2022. [DOI: 10.1016/b978-0-323-85718-5.00002-9] [Reference Citation Analysis]
31 Thorat ST, Rane VV, Bajaj R, Damle A, Patil N, Pawar P. Correlation of Low HDL and High Triglycerides with Outcome in Patients with COVID 19 Infection. jemds 2021;10:3880-3883. [DOI: 10.14260/jemds/2021/784] [Reference Citation Analysis]
32 Castañé H, Iftimie S, Baiges-gaya G, Rodríguez-tomàs E, Jiménez-franco A, López-azcona AF, Garrido P, Castro A, Camps J, Joven J. Machine learning identified distinct serum lipidomic signatures in hospitalized COVID-19-positive and COVID-19-negative patients.. [DOI: 10.1101/2021.12.14.21267764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Zickler M, Stanelle-Bertram S, Ehret S, Heinrich F, Lange P, Schaumburg B, Kouassi NM, Beck S, Jaeckstein MY, Mann O, Krasemann S, Schroeder M, Jarczak D, Nierhaus A, Kluge S, Peschka M, Schlüter H, Renné T, Pueschel K, Kloetgen A, Scheja L, Ondruschka B, Heeren J, Gabriel G. Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans. Cell Metab 2021:S1550-4131(21)00621-5. [PMID: 34895500 DOI: 10.1016/j.cmet.2021.12.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
34 Kalita B, Saviola AJ, Samuel SP, Mukherjee AK. State-of-the-art review - A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis? Int J Biol Macromol 2021;192:1040-57. [PMID: 34656540 DOI: 10.1016/j.ijbiomac.2021.10.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Appiasie D, Guerra DJ, Tanguay K, Jelinek S, Guerra DD, Sen R. “Multiomics” Approaches to Understand and Treat COVID-19: Mass Spectrometry and Next-Generation Sequencing. BioChem 2021;1:210-237. [DOI: 10.3390/biochem1030016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Luporini RL, Pott-Junior H, Di Medeiros Leal MCB, Castro A, Ferreira AG, Cominetti MR, de Freitas Anibal F. Phenylalanine and COVID-19: Tracking disease severity markers. Int Immunopharmacol 2021;101:108313. [PMID: 34741868 DOI: 10.1016/j.intimp.2021.108313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Nikitopoulou I, Fanidis D, Ntatsoulis K, Moulos P, Mpekoulis G, Evangelidou M, Vassiliou AG, Dimakopoulou V, Jahaj E, Tsipilis S, Orfanos SE, Dimopoulou I, Angelakis E, Akinosoglou K, Vassilaki N, Tzouvelekis A, Kotanidou A, Aidinis V. Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells. Int J Mol Sci 2021;22:10006. [PMID: 34576169 DOI: 10.3390/ijms221810006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
38 Mussap M, Fanos V. Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows. Clin Chem Lab Med 2021. [PMID: 34332518 DOI: 10.1515/cclm-2021-0414] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
39 Westheim AJF, Bitorina AV, Theys J, Shiri-Sverdlov R. COVID-19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances. Obes Rev 2021;22:e13313. [PMID: 34269511 DOI: 10.1111/obr.13313] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
40 Barberis E, Amede E, Tavecchia M, Marengo E, Cittone MG, Rizzi E, Pedrinelli AR, Tonello S, Minisini R, Pirisi M, Manfredi M, Sainaghi PP. Understanding protection from SARS-CoV-2 using metabolomics. Sci Rep 2021;11:13796. [PMID: 34226622 DOI: 10.1038/s41598-021-93260-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
41 Stasi A, Franzin R, Fiorentino M, Squiccimarro E, Castellano G, Gesualdo L. Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications. Int J Mol Sci 2021;22:5980. [PMID: 34205975 DOI: 10.3390/ijms22115980] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
42 Martinez MA, Franco S. Impact of COVID-19 in Liver Disease Progression. Hepatol Commun 2021. [PMID: 34222744 DOI: 10.1002/hep4.1745] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
43 Rezaei A, Neshat S, Heshmat-Ghahdarijani K. Alterations of Lipid Profile in COVID-19: A Narrative Review. Curr Probl Cardiol 2021;:100907. [PMID: 34272088 DOI: 10.1016/j.cpcardiol.2021.100907] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
44 Costa ÍF, Bonifácio LP, Bellissimo-Rodrigues F, Rocha EM, Jorge R, Bollela VR, Antunes-Foschini R. Ocular findings among patients surviving COVID-19. Sci Rep 2021;11:11085. [PMID: 34040094 DOI: 10.1038/s41598-021-90482-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
45 Li Y, Liu D, Wang Y, Su W, Liu G, Dong W. The Importance of Glycans of Viral and Host Proteins in Enveloped Virus Infection. Front Immunol 2021;12:638573. [PMID: 33995356 DOI: 10.3389/fimmu.2021.638573] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]